Unnamed: 0,title,date,stock,sentiment
149744.0,"Shares of several healthcare companies are trading higher on continued optimism amid the reopening of the economy, which would increase consumer spending and economic activity.",2020-06-08 11:41:00-04:00,BDSI,positive
149745.0,BioDelivery Sciences Names Jeff Bailey Interim CEO,2020-05-11 08:52:00-04:00,BDSI,neutral
149746.0,"BioDelivery Sciences Intl Q1 EPS $0.050 Beats $0.020 Estimate, Sales $38.300M Beat $33.580M Estimate",2020-05-07 16:31:00-04:00,BDSI,neutral
149747.0,BioDelivery Sciences Intl Option Alert: May 15 $5 Calls Sweep (34) near the Ask: 500 @ $0.25 vs 303 OI; Earnings 5/7 After Close Ref=$4.77,2020-05-07 15:45:00-04:00,BDSI,positive
149748.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,BDSI,negative
149749.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,BDSI,neutral
149750.0,"Shares of several healthcare companies are trading higher as equities gain strength on news that some U.S. states will reopen their economies in phases, increasing economic activity and optimism around the coronavirus pandemic.",2020-04-27 13:19:00-04:00,BDSI,positive
149751.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,BDSI,negative
149752.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,BDSI,negative
149753.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,BDSI,positive
149754.0,"BioDelivery Sciences Intl Q4 EPS $(0.18) May Not Compare To $0.01 Estimate, Sales $31.6M Beat $31.01M Estimate",2020-03-12 16:02:00-04:00,BDSI,neutral
149755.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,BDSI,negative
149756.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,BDSI,negative
149757.0,"Earnings Scheduled For March 12, 2020",2020-03-12 04:51:00-04:00,BDSI,neutral
149758.0,BioDelivery Sciences Appoints Jeffrey A. Bailey To Its Board Of Directors,2020-03-09 08:02:00-04:00,BDSI,neutral
149759.0,"The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues",2020-03-08 16:14:00-04:00,BDSI,negative
149760.0,"BioDelivery Sciences Sees 2019 Net Sales at the Top End of its Previously Given Guidance, Sees 2020 Net Sales Guidance of $165M to $175M",2020-01-13 08:46:00-05:00,BDSI,positive
149761.0,60 Biggest Movers From Yesterday,2019-12-27 04:44:00-05:00,BDSI,neutral
149762.0,34 Stocks Moving In Thursday's Mid-Day Session,2019-12-26 12:11:00-05:00,BDSI,neutral
149763.0,BioDelivery Sciences International shares are trading higher. Not seeing any news to justify the price action.,2019-12-26 10:51:00-05:00,BDSI,positive
149764.0,BioDelivery Sciences Added To NASDAQ Biotechnology Index,2019-12-19 08:38:00-05:00,BDSI,neutral
149765.0,"SunTrust Robinson Humphrey Maintains Buy on BioDelivery Sciences Intl, Raises Price Target to $9",2019-12-18 09:39:00-05:00,BDSI,neutral
149766.0,"The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial",2019-12-03 07:59:00-05:00,BDSI,neutral
149767.0,Stocks That Hit 52-Week Highs On Monday,2019-12-02 10:15:00-05:00,BDSI,neutral
149768.0,Stocks That Hit 52-Week Highs On Friday,2019-11-29 10:28:00-05:00,BDSI,neutral
149769.0,"The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing",2019-11-14 08:07:00-05:00,BDSI,positive
149770.0,54 Stocks Moving In Wednesday's Mid-Day Session,2019-11-13 12:08:00-05:00,BDSI,neutral
149771.0,Stocks That Hit 52-Week Highs On Wednesday,2019-11-13 10:12:00-05:00,BDSI,neutral
149772.0,44 Stocks Moving in Wednesday's Pre-Market Session,2019-11-13 07:19:00-05:00,BDSI,neutral
149773.0,BioDelivery Sciences International shares are trading higher after the company reported better-than-expected Q3 EPS and sales results.,2019-11-12 17:09:00-05:00,BDSI,positive
149774.0,"BioDelivery Sciences Intl Q3 EPS $0.03 Beats $(0.02) Estimate, Sales $30.306M Beat $28.28M Estimate",2019-11-12 16:29:00-05:00,BDSI,neutral
149775.0,"The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat",2019-11-12 07:20:00-05:00,BDSI,neutral
149776.0,Stocks That Hit 52-Week Highs On Wednesday,2019-10-30 10:35:00-04:00,BDSI,neutral
149777.0,Stocks That Hit 52-Week Highs On Tuesday,2019-10-29 10:52:00-04:00,BDSI,neutral
149778.0,Stocks That Hit 52-Week Highs On Monday,2019-10-28 10:51:00-04:00,BDSI,neutral
149779.0,Stocks That Hit 52-Week Highs On Friday,2019-10-25 12:47:00-04:00,BDSI,neutral
149780.0,BioDelivery Sciences Announces 'Significant' Additional Insurance Coverage For Both BELBUCA And Symproic,2019-10-01 08:09:00-04:00,BDSI,neutral
149781.0,BioDelivery Sciences Announces Five Medical Abstracts Accepted At PAINWeek 2019 National Conference On Pain Management,2019-08-28 07:48:00-04:00,BDSI,negative
149782.0,BioDelivery Sciences International shares are trading higher after the company reported better-than-expected Q2 sales results.,2019-08-09 15:57:00-04:00,BDSI,positive
149783.0,BioDelivery Sciences International shares are trading higher after the company reported better-than-expected Q2 sales results.,2019-08-08 16:23:00-04:00,BDSI,positive
149784.0,"BioDelivery Sciences Intl Q2 EPS $(0.13) Misses $(0.06) Estimate, Sales $29.677M Beat $24.72M Estimate",2019-08-08 16:21:00-04:00,BDSI,negative
149785.0,"The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering",2019-08-08 07:11:00-04:00,BDSI,neutral
149786.0,45 Healthcare Stocks Moving In Monday's After-Market Session,2019-07-30 04:54:00-04:00,BDSI,neutral
149787.0,BioDelivery Sciences S-3 Shows $125M Mixed Securities Offering,2019-07-29 17:05:00-04:00,BDSI,positive
149788.0,BioDelivery Sciences Announces Further Improved Insurance Coverage For BELBUCA,2019-07-09 08:09:00-04:00,BDSI,positive
149789.0,18 Stocks Joining The Russell Indices,2019-06-28 14:19:00-04:00,BDSI,neutral
149790.0,BioDelivery Sciences To Join Russell 3000 Index. Effective Jul. 1,2019-06-20 08:07:00-04:00,BDSI,positive
149791.0,28 Stocks Moving In Wednesday's Pre-Market Session,2019-05-29 08:16:00-04:00,BDSI,neutral
149792.0,BioDelivery Sciences International shares are trading higher after the company announced debt refinancing to strengthen its financial position.,2019-05-28 16:29:00-04:00,BDSI,positive
149793.0,BioDelivery Sciences Announces Debt Refinancing,2019-05-28 16:28:00-04:00,BDSI,negative
149794.0,"BioDelivery Sciences Q1 EPS $(0.05) Beats $(0.08) Estimate, Sales $19.76M Beat $19.32M Estimate",2019-05-06 16:09:00-04:00,BDSI,neutral
149795.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,BDSI,positive
149796.0,28 Stocks Moving In Thursday's Pre-Market Session,2019-04-11 08:03:00-04:00,BDSI,neutral
149797.0,"The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug",2019-04-11 07:48:00-04:00,BDSI,positive
149798.0,4 Stocks Moving In Wednesday's After-Hours Session,2019-04-10 17:10:00-04:00,BDSI,neutral
149799.0,BioDelivery Services shares trading lower following news of a common stock offering. The company also announced it will purchase the US commercial rights to Symproic.,2019-04-10 16:09:00-04:00,BDSI,neutral
149800.0,"BioDelivery Services Reports Offering Of Common Shares, No Size Disclosed",2019-04-10 16:08:00-04:00,BDSI,neutral
149801.0,BioDelivery Sciences Now Sees Total FY19 Sales $92M-$100M With Sympronic Sales Of $7M-$9M,2019-04-10 16:07:00-04:00,BDSI,neutral
149802.0,BioDelivery Sciences Acquires US Commercial Rights To Symproic; Co. Will Pay Initial $20M Upfront And Additional $10M In Six Months,2019-04-10 16:06:00-04:00,BDSI,negative
149803.0,"The Daily Biotech Pulse: Biogen Plummets, FDA Greenlights Sleep Disorder Drug, Cellular Biomedicine Offering",2019-03-21 07:51:00-04:00,BDSI,negative
149804.0,"SunTrust Robinson Humphrey Initiates Coverage On BioDelivery Sciences Intl with Buy Rating, Announces $7 Price Target",2019-03-20 07:22:00-04:00,BDSI,neutral
149805.0,BioDelivery Sciences International shares are trading higher after the company reported better-than-expected Q4 results and issued strong guidance.,2019-03-15 09:31:00-04:00,BDSI,positive
149806.0,"The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering",2019-03-14 07:47:00-04:00,BDSI,neutral
149807.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs",2019-03-10 14:32:00-04:00,BDSI,neutral
149808.0,'BDSI – Money Losing Opioid Company Founded By The Bankruptcy Experts' -Fuzzy Panda Research,2019-03-08 10:01:00-05:00,BDSI,negative
149809.0,"BioDelivery Sciences International On Mar. 1 Filed Patent Infringement Complaint Against Chemo Research, Insud Pharma S.L., IntelGenx Corp., And IntelGenx Technologies Corp",2019-03-04 07:46:00-05:00,BDSI,negative
149810.0,"The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering",2019-02-20 07:34:00-05:00,BDSI,negative
149811.0,BioDelivery Announces Expanded Preferred Insurance Coverage For BELBUCA,2019-02-04 08:18:00-05:00,BDSI,neutral
149812.0,"The Daily Biotech Pulse: Merck Earnings, Positive Relaunch Of  Titan's Opioid Disorder Treatment Implant",2019-02-01 09:10:00-05:00,BDSI,positive
149813.0,"Benzinga's Top Upgrades, Downgrades For January 31, 2019",2019-01-31 09:11:00-05:00,BDSI,positive
149814.0,Janney Capital Assumes BioDelivery Sciences Intl at Buy,2019-01-31 08:33:00-05:00,BDSI,neutral
149815.0,"The Daily Biotech Pulse: Roche Scraps Alzheimer's Disease Trials, Amgen Issues Weak Guidance",2019-01-30 08:12:00-05:00,BDSI,negative
149816.0,"The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive",2019-01-29 07:25:00-05:00,BDSI,neutral
149817.0,"Stocks Which Set New 52-Week High Mon., Jan. 28, 2019",2019-01-28 15:32:00-05:00,BDSI,neutral
149818.0,"The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US",2019-01-17 08:06:00-05:00,BDSI,positive
149819.0,BioDelivery Sciences Intl Option Alert: Feb 15 $4 Calls at the Ask: 2045 @ $0.551 vs 426 OI; Earnings 3/14 After Close [est] Ref=$4.285,2019-01-16 10:03:00-05:00,BDSI,positive
149820.0,"Stocks Which Set New 52-Week High Fri., Jan. 11, 2019",2019-01-14 09:47:00-05:00,BDSI,neutral
149821.0,48 Biggest Movers From Friday,2018-12-31 05:18:00-05:00,BDSI,neutral
149822.0,What's Going On With Adial Pharmaceuticals?,2018-11-30 14:03:00-05:00,BDSI,neutral
149823.0,"The Daily Biotech Pulse: SITC Presentations Pick Up Pace, Sandoz' Voluntary Recall",2018-11-09 07:32:00-05:00,BDSI,neutral
149824.0,"BioDelivery Sciences Q3 EPS $(0.10) Beats $(0.14) Estimate, Sales $14.2M Beat $13.93M Estimate",2018-11-08 16:59:00-05:00,BDSI,neutral
149825.0,"The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering",2018-11-08 08:10:00-05:00,BDSI,negative
149826.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,BDSI,neutral
149827.0,BioDelivery Scciences Announces a US Pharmacy Benefit Manger Has Added its BELBUCA to Their National Preferred Formulary List,2018-11-01 17:51:00-04:00,BDSI,positive
149828.0,"Stocks Which Set New 52-Week High Yesterday, October 29th",2018-10-30 12:35:00-04:00,BDSI,neutral
149829.0,"The Daily Biotech Pulse: Enzo's Q4 Loss, Sanofi's Positive Trial Results, ImmunoCellular To Delist",2018-10-16 08:52:00-04:00,BDSI,positive
149830.0,"Stocks Which Set New 52-Week High Yesterday, October 9th",2018-10-10 10:57:00-04:00,BDSI,neutral
149831.0,"The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares",2018-10-10 07:56:00-04:00,BDSI,positive
149832.0,"The Daily Biotech Pulse: Affimed's Cancer Drug Placed On Clinical Hold, Celgene's Positive Scalp Psoriasis Trial",2018-10-09 08:03:00-04:00,BDSI,negative
149833.0,44 Biggest Movers From Yesterday,2018-10-09 05:27:00-04:00,BDSI,neutral
149834.0,BioDelivery Sciences Secures Significant Expanded Preferred Coverage for BELBUCA From A Leading PBM,2018-08-15 09:27:00-04:00,BDSI,positive
149835.0,"BioDelivery Sciences Q2 EPS $(0.16) Beats $(0.18) Estimate, Sales $12.175M Miss $12.27M Estimate",2018-08-09 16:47:00-04:00,BDSI,negative
149836.0,"The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings",2018-08-09 08:39:00-04:00,BDSI,positive
149837.0,"William Blair Views 4 Biotech/Pharma Stocks As 'Top Picks': Adamas Pharma, Aclaris Therapeutics, Biodelivery Sciences, Exelixis",2018-07-19 06:26:00-04:00,BDSI,positive
149838.0,Analyst: Opioid Legislation Likely Stalled In Senate Until After November Elections,2018-07-14 13:54:00-04:00,BDSI,negative
149839.0,45 Biggest Movers From Yesterday,2018-05-25 04:37:00-04:00,BDSI,neutral
149840.0,Mid-Afternoon Market Update: Dow Turns Lower; J C Penney Shares Plunge,2018-05-17 14:32:00-04:00,BDSI,neutral
149841.0,"BioDelivery Sciences Shares Up 20.5% After Co. Earlier Announced Board Restructuring Plan And $50M Equity Financing Deal Led By Broadfin To ""Significantly Strengthen"" Financial Position",2018-05-17 13:17:00-04:00,BDSI,positive
149842.0,BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business By Reconstructing The Board; Also Announced A $50M Equity Financing Deal Led By Broadfin,2018-05-17 08:06:00-04:00,BDSI,positive
149843.0,"BioDelivery Sciences Q1 EPS $(0.18) Beats $(0.21) Estimate, Sales $11.28M Beat $11.15M Estimate",2018-05-10 16:10:00-04:00,BDSI,neutral
149844.0,"Benzinga's Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer's Trial Results",2018-05-10 09:44:00-04:00,BDSI,neutral
149845.0,BioDelivery Sciences Names Herm Cukier CEO,2018-05-07 09:05:00-04:00,BDSI,neutral
149846.0,"The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More",2018-05-06 18:19:00-04:00,BDSI,neutral
149847.0,BioDelivery Sciences Confirms Receipt of Notice of Intent to Nominate Directors by Broadfin Capital,2018-05-03 09:01:00-04:00,BDSI,neutral
149848.0,Broadfin Capital Reports 7.3% Stake In Biodelivery Sciences as of April 5,2018-04-10 06:12:00-04:00,BDSI,neutral
149849.0,"BioDelivery Sciences Reports Q4 EPS $(0.29) vs $(0.24) Est., Sales $12.5M vs $9.77M Est.",2018-03-15 16:04:00-04:00,BDSI,neutral
149850.0,"Earnings Scheduled For March 15, 2018",2018-03-15 04:17:00-04:00,BDSI,neutral
149851.0,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",2018-03-11 16:58:00-04:00,BDSI,neutral
149852.0,BioDelivery Sciences Announces BELBUCA Patent Litigation Settlement Agreement with Teva,2018-02-06 07:14:00-05:00,BDSI,positive
149853.0,BioDelivery Sciences Announces Launch and Availability of BELBUCA in Canada,2018-01-30 08:05:00-05:00,BDSI,neutral
149854.0,"Seaport Global Initiates Coverage On BioDelivery Sciences Intl with Buy Rating, Announces $5.00 Price Target",2018-01-26 08:05:00-05:00,BDSI,neutral
149855.0,BioDelivery Sciences Names Scott Plesha Pres,2017-12-20 08:45:00-05:00,BDSI,neutral
149856.0,34 Stocks Moving In Monday's Mid-Day Session,2017-12-18 12:28:00-05:00,BDSI,neutral
149857.0,31 Stocks Moving In Monday's Pre-Market Session,2017-12-18 08:12:00-05:00,BDSI,neutral
149858.0,BioDelivery Sciences Announces Notice of Allowance of Patent Strengthening Patent Protection on BELBUCA to 2032,2017-12-18 07:18:00-05:00,BDSI,positive
149859.0,BioDelivery Sciences Reports Notice of Allowance of Patent Strengthening Patent Protection on BELBUCA to 2032,2017-12-18 07:03:00-05:00,BDSI,positive
149860.0,"BioDelivery Sciences Reports Reacquisition Of ONSOLIS From Collegium Pharma, No Terms; Termination Of Deal Will Be Effective Mar. 8, 2018",2017-12-14 16:32:00-05:00,BDSI,positive
149861.0,"BioDelivery Sciences Reports Q3 EPS $(0.21) vs $(0.22) Est., Sales $11.3M vs $9.39M Est.",2017-11-09 16:32:00-05:00,BDSI,neutral
149862.0,22 Stocks To Watch After President Trump Declares Opioid Epidemic A National Health Emergency,2017-10-26 15:24:00-04:00,BDSI,negative
149863.0,Pres Trump Implies Top Priority Is Removing Fentanyl From Market,2017-10-26 14:37:00-04:00,BDSI,positive
149864.0,Watching Opioid-Related Stocks As Pres Trump Declares America's Opioid Epidemic A National Public Health Emergency,2017-10-26 14:33:00-04:00,BDSI,negative
149865.0,"BioDelivery Sciences Reports Patent Litigation Settlement Agreement with Teva, BDSI Enters Non-Exclusive Licensing Agreement With Teva That Permits Teva To Begin Selling A Generic In July 2028, Other Terms Not Disclosed",2017-10-12 07:02:00-04:00,BDSI,positive
149866.0,Mid-Afternoon Market Update: Crude Oil Down Over 1%; Synchronoss Technologies Shares Slide,2017-09-19 14:38:00-04:00,BDSI,negative
149867.0,UPDATE: BioDelivery Sciences Says Transfer Of NDS To Purdue Pharma (Canada) Triggers Milestone Payment To BDSI,2017-09-12 08:08:00-04:00,BDSI,neutral
149868.0,BioDelivery Sciences Reports Granting Of Market Authorization Transfer By Health Canada For BELBUCA,2017-09-12 08:07:00-04:00,BDSI,positive
149869.0,"BioDelivery Sciences Reports Pres, CEO Mark Sirgo To Retire, Will Continue As Vice Chair",2017-08-23 07:33:00-04:00,BDSI,neutral
149870.0,"BioDelivery Sciences International Reports Q2 EPS $(0.27) vs $(0.24) Est., Sales $8.7M vs $8.45M Est.",2017-08-09 17:04:00-04:00,BDSI,neutral
149871.0,22 Stocks Moving In Wednesday's Pre-Market Session,2017-07-12 08:06:00-04:00,BDSI,neutral
149872.0,"BioDelivery Sciences Reports Signing Of Exclusive Deal With Purdue Pharma Related To Licensing, Distribution Rights Of BELBUCA In Canada",2017-07-12 07:31:00-04:00,BDSI,positive
149873.0,BioDelivery Sciences Reports Health Canada Approval Of BELBUCA,2017-06-23 07:04:00-04:00,BDSI,positive
149874.0,Mid-Afternoon Market Update: Crude Oil Down 3%; La-Z-Boy Shares Gain On Earnings Beat,2017-06-21 14:31:00-04:00,BDSI,positive
149875.0,"BioDelivery Sciences Reports Deal With CVS/Caremark For BELBUCA, BUNAVAIL Through '20",2017-06-21 09:08:00-04:00,BDSI,neutral
149876.0,22 Stocks Moving In Friday's Pre-Market Session,2017-05-26 08:31:00-04:00,BDSI,neutral
149877.0,Mid-Morning Market Update: Markets Mostly Higher; Wal-Mart Profit Tops Estimates,2017-05-18 10:10:00-04:00,BDSI,positive
149878.0,15 Biggest Mid-Day Gainers For Wednesday,2017-05-17 12:31:00-04:00,BDSI,neutral
149879.0,"Benzinga's Top Upgrades, Downgrades For May 17, 2017",2017-05-17 09:25:00-04:00,BDSI,positive
149880.0,Cantor Fitzgerald Upgrades BioDelivery Sciences Intl to Overweight,2017-05-17 06:27:00-04:00,BDSI,negative
149881.0,25 Stocks Moving In Tuesday's Pre-Market Session,2017-05-16 08:05:00-04:00,BDSI,neutral
149882.0,"BioDelivery Sciences Reports Q1 EPS $0.89 May Not Compare To $0.12 Est., Sales $29.5M vs $27.53M Est.",2017-05-15 17:12:00-04:00,BDSI,neutral
149883.0,"BioDelivery Sciences Reports Q1 EPS $0.87 vs $(0.36) in Same Qtr. Last Year, Sales $29.5M",2017-05-15 16:05:00-04:00,BDSI,neutral
149884.0,"Earnings Scheduled For May 15, 2017",2017-05-15 05:12:00-04:00,BDSI,neutral
149885.0,BioDelivery Sciences Files for Non-Timely 10-Q,2017-05-10 16:34:00-04:00,BDSI,neutral
149886.0,18 Biggest Mid-Day Gainers For Tuesday,2017-05-02 12:28:00-04:00,BDSI,neutral
149887.0,25 Stocks Moving In Tuesday's Pre-Market Session,2017-05-02 08:05:00-04:00,BDSI,neutral
149888.0,BioDelivery Sciences Reports Approval of BUNAVAIL for Induction of Buprenorphine Treatment for Opioid Dependence,2017-05-02 07:11:00-04:00,BDSI,positive
149889.0,15 Biggest Mid-Day Gainers For Friday,2017-03-31 12:23:00-04:00,BDSI,neutral
149890.0,18 Stocks Moving In Friday's Pre-Market Session,2017-03-31 08:26:00-04:00,BDSI,neutral
149891.0,"BioDelivery Sciences Granted 2 New Patents Listed In FDA Orange Book Straightening Patent Protection For BELBUCA, BUNAVAIL and ONSOLIS",2017-03-31 07:06:00-04:00,BDSI,positive
149892.0,"BioDelivery Sciences Reports Q4 EPS $(0.29) vs $(0.26) Est., Sales ~$3.9M vs $3.88M Est.",2017-03-17 06:30:00-04:00,BDSI,neutral
149893.0,"Earnings Scheduled For March 17, 2017",2017-03-17 05:11:00-04:00,BDSI,neutral
149894.0,BioDelivery Sciences Announces Three Data Presentations on BELBUCA at the American Academy of Pain Medicine 33rd Annual Meeting,2017-03-16 09:29:00-04:00,BDSI,negative
149895.0,MonoSol RX Files Patent Infringement Suit Against BioDelivery Sciences,2017-01-13 15:40:00-05:00,BDSI,negative
149896.0,13G Filing Shows Stonepine Capital Reporting 6% Stake In Biodelivery Sciences,2017-01-13 15:36:00-05:00,BDSI,neutral
149897.0,15 Biggest Mid-Day Losers For Tuesday,2016-12-13 12:53:00-05:00,BDSI,negative
149898.0,Mid-Morning Market Update: Markets Open Higher; VeriFone Issues Weak Forecast,2016-12-13 09:51:00-05:00,BDSI,negative
149899.0,BioDelivery Says Clonidine Topical Gel Phase 2b Trial Missed Primary Endpoint,2016-12-13 06:57:00-05:00,BDSI,negative
149900.0,"Belbuca Revenue 'Immaterial,' Says JMP On Rx's Return To BioDelivery From Endo International",2016-12-09 10:36:00-05:00,BDSI,neutral
149901.0,10 Stocks With Lowest Close In Three Weeks,2016-12-09 05:34:00-05:00,BDSI,negative
149902.0,Endo to Eliminate 375 Member Pain Salesforce Following Sale of Belbuca to BDSI,2016-12-08 06:17:00-05:00,BDSI,negative
149903.0,"BioDelivery Sciences Reacquires License to BELBUCA™ from Endo Pharmaceuticals, Terms Not Disclosed",2016-12-08 06:03:00-05:00,BDSI,neutral
149904.0,"10 Stocks That Rallied Four Days, Then Sold Off Yesterday",2016-12-07 04:58:00-05:00,BDSI,neutral
149905.0,Stocks Hitting 52-Week Lows,2016-11-23 10:27:00-05:00,BDSI,negative
149906.0,Stifel Healthcare Conference Today,2016-11-15 10:53:00-05:00,BDSI,neutral
149907.0,"BioDelivery Q3 EPS $(0.30) vs $(0.25) Est, Revenue $3.57M vs $3.58M Est",2016-11-09 06:03:00-05:00,BDSI,neutral
149908.0,BioDelivery Sciences Announces Preferred Formulary Status for BUNAVAIL on Texas Medicaid,2016-10-24 07:02:00-04:00,BDSI,neutral
149909.0,Biodelivery Sciences Shares Bounce Off Session Lows as Some Traders Passing Around Positive Seeking Alpha Article Which Suggests $6 Price Target,2016-10-13 10:01:00-04:00,BDSI,positive
149910.0,"18 Stocks Which Rallied Four Days, Then Sold Off Yesterday",2016-09-30 10:59:00-04:00,BDSI,neutral
149911.0,"BioDelivery Sciences Announces SAMHSA Has Reported 1,665 Clinicians Granted Waivers at Increased Limit",2016-09-30 07:02:00-04:00,BDSI,positive
149912.0,Mid-Afternoon Market Update: Dow Falls Over 200 Points; Catabasis Shares Spike Higher,2016-09-29 14:38:00-04:00,BDSI,positive
149913.0,Watch These 5 Huge Call Purchases In Wednesday Trade,2016-09-28 02:22:00-04:00,BDSI,positive
149914.0,Option Alert: BDSI Dec16 3.0 Calls Sweep: 743 @  ASK  $0.45: 1465 traded vs 839 OI:  Earnings 11/14  $2.80 Ref,2016-09-27 15:39:00-04:00,BDSI,positive
149915.0,18 Biggest Mid-Day Gainers For Friday,2016-09-23 12:39:00-04:00,BDSI,neutral
149916.0,Benzinga's Top Upgrades,2016-09-23 09:20:00-04:00,BDSI,positive
149917.0,Janney Capital Upgrades BioDelivery Sciences Intl to Buy,2016-09-23 08:33:00-04:00,BDSI,neutral
149918.0,15 Stocks Moving In Friday's Pre-Market Session,2016-09-23 08:17:00-04:00,BDSI,neutral
149919.0,BioDelivery Sciences Announces 3 Managed Care Agreements for BUNAVAIL,2016-09-19 07:12:00-04:00,BDSI,positive
149920.0,15 Stocks With Three-Day Increasing Volume,2016-09-16 06:58:00-04:00,BDSI,neutral
149921.0,5 Stocks Which Plummeted Three Days On Increasing Volume,2016-09-16 06:50:00-04:00,BDSI,neutral
149922.0,"BioDelivery Q2 EPS ($0.31) vs ($0.31) est, Revenue $5.0M vs $3.4M est",2016-08-09 06:15:00-04:00,BDSI,neutral
149923.0,BioDelivery Sciences Announces the Securing of Preferred Formulary Status for BUNAVAIL on a Significant Managed Care Plan,2016-07-11 16:01:00-04:00,BDSI,positive
149924.0,White House To Loosen Controls On Heroin Addiction Treatment,2016-07-06 09:00:00-04:00,BDSI,negative
149925.0,"Endo Pharmaceuticals Reports Safety, Tolerability Of BELBUCA At ICOO In Boston For June 5-7th",2016-06-03 08:02:00-04:00,BDSI,positive
149926.0,"Shares of BioDelivery Spike To High Of $2.37/Share, Up 12.3% On The Day",2016-05-31 11:44:00-04:00,BDSI,positive
149927.0,Option Alert: BDSI Jun16 3.0 Calls Sweep: 547 @  ASK  $0.05: 547 traded vs 102 OI: $2.34 Ref,2016-05-31 11:44:00-04:00,BDSI,positive
149928.0,FDA Approves New Opioid Addiction Treatment Tech,2016-05-27 11:56:00-04:00,BDSI,positive
149929.0,Stocks Hitting 52-Week Lows,2016-05-23 10:27:00-04:00,BDSI,negative
149930.0,"Collegium Licenses the U.S. rights to ONSOLIS from BioDelivery Sciences, Will Include $2.5M Upfront Payment With Sales Milestone Payments Of Up To $21M To BioDelivery Sciences",2016-05-11 16:09:00-04:00,BDSI,neutral
149931.0,"Cantor Doesn't Think BioDelivery Sciences Should Be Cutting To Grow, Downgrades Stock To Hold",2016-05-11 09:52:00-04:00,BDSI,negative
149932.0,"Cantor Fitzgerald Downgrades BioDelivery Sciences to Hold, Lowers PT to $5.00",2016-05-11 07:02:00-04:00,BDSI,negative
149933.0,"Biodelivery Sciences Shares Spiking From $1.97 To $2.26, Possibly From 13G Filing Filed By Federated Investors Showing 4.53% Stake",2016-05-10 10:44:00-04:00,BDSI,positive
149934.0,"UPDATE: BioDelivery Reports 'Strong' Cash Position of $69.4M as of Mar. 31, '16",2016-05-10 07:29:00-04:00,BDSI,neutral
149935.0,Biodelivery Sciences Filing of Buprenorphine 30 Day Injection to Treat Opioid Dependence and Chronic Pain Anticipated in Q3 2016,2016-05-10 07:07:00-04:00,BDSI,negative
149936.0,Mid-Afternoon Market Update: U.S. Stocks Turn Higher; Endo International Shares Plunge,2016-05-06 14:30:00-04:00,BDSI,positive
149937.0,BioDelivery Sciences Reports Acceptance of Abstract to ICO on Impact of State Formulary Conversion to BUNAVAIL,2016-04-29 07:14:00-04:00,BDSI,positive
149938.0,"MonoSol Rx Announces US PTO Has Upheld Validity of Co.'s Patent No. 8,765,167 Brought by BioDelivery Sciences",2016-04-07 08:31:00-04:00,BDSI,negative
149939.0,BioDelivery Sciences Q4 Earnings Conference Call: Full Transcript,2016-03-11 12:25:00-05:00,BDSI,neutral
149940.0,"Roth Capital Maintains Buy on BioDelivery Sciences, Lowers PT to $9.00",2016-03-11 08:21:00-05:00,BDSI,negative
149941.0,"BioDelivery Sciences Reports FY15 EPS $(0.72) vs $(1.12) in Same Qtr. Last Year, Sales $48.23M vs $52M Est.",2016-03-10 16:10:00-05:00,BDSI,neutral
149942.0,Endo Reports Launch Of BELBUCA Buccal Film For Chronic Pain Management,2016-02-22 07:31:00-05:00,BDSI,negative
149943.0,"Piper Jaffray Assumes BioDelivery Sciences at Overweight, Announces $6.00 PT",2016-02-08 06:44:00-05:00,BDSI,negative
149944.0,Stocks Hitting 52-Week Lows,2016-01-14 10:24:00-05:00,BDSI,negative
149945.0,"BioDelivery Says Clonidine Topical Clinical Trial Underway For Treatment Of Painful Diabetic Neuropathy, Will Give More Pipeline Update On R&D Day Planned For Early 2016",2015-12-18 08:34:00-05:00,BDSI,negative
149946.0,BioDelivery Sciences Announces Organizational Changes,2015-12-16 17:10:00-05:00,BDSI,neutral
149947.0,BioDelivery Sciences Hires Joseph M. Lockhart as VP of Manufacturing and Supply Chain,2015-12-03 07:01:00-05:00,BDSI,neutral
149948.0,"BioDelivery Sciences Reports Q3 EPS $(0.39) vs $(0.33) Est., Sales $1.6M vs $1.6M Est.",2015-11-09 07:12:00-05:00,BDSI,neutral
149949.0,BioDelivery Sciences +20% Premarket Following Announcement of $50M Milestone Payment from Endo,2015-10-26 07:03:00-04:00,BDSI,neutral
149950.0,FDA Approval of BELBUCA Buccal Film for Chronic Pain Triggers Milestone Payment of $50 Million to BioDelivery Sciences from Partner Endo Pharmaceuticals,2015-10-26 07:00:00-04:00,BDSI,negative
149951.0,FDA Approves BELBUCA Buccal Film for Chronic Pain Management,2015-10-26 06:01:00-04:00,BDSI,negative
149952.0,BioDelivery Sciences +11 Following Announcement of FDA Approval of Change in BUNAVAIL Product Specification,2015-10-15 07:43:00-04:00,BDSI,positive
149953.0,BioDelivery Sciences Announces FDA Approval of Change in BUNAVAIL® Product Specification Allowing for Immediate Release of Product,2015-10-15 07:30:00-04:00,BDSI,positive
149954.0,"UPDATE: BioDelivery Reports FDA Has Told Co. Decision Related to Requested Specification Change Expected Within Days, No Later Than Next Week",2015-10-14 07:19:00-04:00,BDSI,negative
149955.0,UPDATE: BioDelivery Sciences Says Delay Related to Recent Intro of a New Source of Standard Polymer by Supplier,2015-10-14 07:18:00-04:00,BDSI,negative
149956.0,BioDelivery Reports Short-Term Supply Constraints for BUNAVAIL,2015-10-14 07:17:00-04:00,BDSI,neutral
149957.0,"BioDelivery Sciences Investors Have Been Burned, But Inflection Point Could Be Coming",2015-10-06 08:16:00-04:00,BDSI,neutral
149958.0,Option Alert: $BDSI Nov $6 Call; 2000 Contracts @Ask @$0.80; Now $4.82,2015-09-29 13:56:00-04:00,BDSI,positive
149959.0,"Jim Cramer Advises His Viewers On Starwood Hotels & Resorts, Intrexon, BioDelivery Sciences And Ford Motor",2015-09-24 07:04:00-04:00,BDSI,neutral
149960.0,"Endo Pharmaceuticals, BioDelivery Sciences Present Promising Data On New Chronic Pain Management Product",2015-09-10 17:17:00-04:00,BDSI,negative
149961.0,Endo Pharmaceuticals and BioDelivery Sciences Present New Data on Investigational Product Buprenorphine HCl Buccal Film for Chronic Pain Management,2015-09-09 07:33:00-04:00,BDSI,negative
149962.0,BioDelivery Sciences Secures Exclusive Preferred Formulary Status for BUNAVAIL® with Tennessee Medicaid (TennCare),2015-09-08 07:02:00-04:00,BDSI,positive
149963.0,BioDelivery Sciences Reports FDA Approval of New Formulation of ONSOLIS® (fentanyl buccal soluble film) CII,2015-08-13 07:03:00-04:00,BDSI,positive
149964.0,Biodelivery Sciences Spikes to High on Volume,2015-08-12 14:33:00-04:00,BDSI,neutral
149965.0,"BioDelivery Reports Q2 Loss $0.37 Vs est Loss $0.31, Sales $1.73M Vs Est $3.28m",2015-08-10 07:02:00-04:00,BDSI,negative
149966.0,S-3 BioDelivery Sciences Shows Registration for $150M Mixed Securities Shelf Offering,2015-07-02 17:16:00-04:00,BDSI,positive
149967.0,BioDelivery Sciences Adds $20M in Debt Financing from MidCap Financial,2015-06-01 07:03:00-04:00,BDSI,negative
149968.0,"Biodelivery Sciences Director D'Alonzo Buys 6,226 Shares @$8.07/Share -Form 4",2015-05-14 16:41:00-04:00,BDSI,positive
149969.0,"Endo Pharma, BioDelivery Sciences Reports Presentation of Pivotal Data from Two Phase 3 Trials Showing Safety, Efficacy of Buprenorphine HCl Buccal Film for Chronic Pain",2015-05-14 16:22:00-04:00,BDSI,negative
149970.0,"Biodelivery Sciences Reports Q1 Loss of $0.16/Share vs Loss of $0.19/Share Est., Sales $13.1M vs $11M Est.",2015-05-11 07:22:00-04:00,BDSI,negative
149971.0,"BioDelivery Sciences Names Dr. Sarah DeRossett VP of Clinical Research, Medical Affairs",2015-04-28 07:07:00-04:00,BDSI,neutral
149972.0,Option Alert: BioDelivery Sciences May $10 Call; 1000 Contract Trade at Ask @$0.30; Now $9.33,2015-04-24 15:49:00-04:00,BDSI,positive
149973.0,"Cantor Fitzgerald Initiates Coverage on BioDelivery Sciences at Buy, Announces $17.00 PT",2015-04-07 16:10:00-04:00,BDSI,neutral
149974.0,"FBR Capital Initiates Coverage on BioDelivery Sciences at Outperform, Announces $19.00 PT",2015-04-02 06:13:00-04:00,BDSI,neutral
149975.0,Morning Market Losers,2015-03-30 09:49:00-04:00,BDSI,negative
149976.0,BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met,2015-03-30 06:31:00-04:00,BDSI,negative
149977.0,"Biodelivery Sciences Reports Q4 Loss of $0.51/Share vs Loss of $0.33/Share Est., Sales $2.5M vs $4M Est.",2015-03-16 16:04:00-04:00,BDSI,negative
149978.0,"Endo Pharma, BioDelivery Sciences Reports Acceptance of NDA for Belbuca",2015-02-23 07:31:00-05:00,BDSI,positive
149979.0,Why Piper Jaffray's Charles Duncan Still Likes Catalyst Pharmaceuticals,2015-02-18 10:15:00-05:00,BDSI,positive
149980.0,Gilead Could Miss Earnings (Hint: Watch Drug Sales),2015-02-02 22:27:00-05:00,BDSI,negative
149981.0,"Biotech Breakdown: Market Breaks...Gilead, Kite Pharma & Biogen Idec Worth Watching",2015-02-01 21:14:00-05:00,BDSI,positive
149982.0,Why The Biotech Boom Is Still In The 1st Inning,2015-02-01 12:35:00-05:00,BDSI,neutral
149983.0,"Biodelivery Sciences Enters Into Definitive Assignment, Revenue Sharing Agreement With Arius Pharmaceuticals, Meda AB",2015-01-28 16:39:00-05:00,BDSI,positive
149984.0,BioDelivery Sciences Acquires Marketing Authorizations for ONSOLIS,2015-01-27 07:04:00-05:00,BDSI,neutral
149985.0,Morning Market Movers,2014-12-24 09:42:00-05:00,BDSI,neutral
149986.0,"Christmas Eve #PreMarket Movers: Digital Ally, Navigator, Cal-Maine Foods, Virgin America And More",2014-12-24 09:04:00-05:00,BDSI,neutral
149987.0,Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain,2014-12-23 16:15:00-05:00,BDSI,negative
149988.0,BioDelivery Sciences Announces Completion of Randomization in Phase 3 Trial of Clonidine Topical Gel for the Treatment of Painful Diabetic Neuropathy,2014-12-08 07:06:00-05:00,BDSI,negative
149989.0,BioDelivery Sciences Reports Availability of BUNAVAIL in US,2014-11-03 07:07:00-05:00,BDSI,neutral
149990.0,Micro-Cap ETF And The Falling Greenback,2014-10-13 17:28:00-04:00,BDSI,negative
149991.0,BioDelivery Sciences Announces The Hiring of J. Chris Prue As VP Of Regulatory Affairs And Quality ,2014-10-10 11:22:00-04:00,BDSI,neutral
149992.0,"Roth Capital Downgrades BioDelivery Sciences International, Inc. to Neutral, Maintains $20.00 PT",2014-10-10 05:37:00-04:00,BDSI,neutral
149993.0,"BioDelivery Sciences to Provide BUNAVAIL Launch Update on Tuesday, October 7 at 8:00 AM ET",2014-10-06 21:01:00-04:00,BDSI,neutral
149994.0,US Patent Office Institutes Inter Partes Review Brought by MonoSol Rx Against All Claims in Key BDSI BEMA Patent ,2014-10-06 09:36:00-04:00,BDSI,neutral
149995.0,"Biodelivery Sciences CEO Sirgo Buys 2,000 Shares @$15.04/Share -Form 4",2014-09-05 07:17:00-04:00,BDSI,positive
149996.0,Hearing BioDelivery Sciences on Fast Money on CNBC Tonight,2014-09-04 15:29:00-04:00,BDSI,neutral
149997.0,Biodelivery Sciences Shares Move Higher on Heavy Volume,2014-08-25 10:43:00-04:00,BDSI,positive
149998.0,BioDelivery Announces Positive NDA Meeting with FDA,2014-08-12 07:01:00-04:00,BDSI,positive
149999.0,"BioDelivery Sciences International, Inc. Reports Q2 EPS of $(0.14) vs $(0.13) Est",2014-08-07 16:48:00-04:00,BDSI,neutral
150000.0,"BioDelivery Says Interim Analysis of Phase 3 Trial Encouraging, Will Enroll 80 Additional Patients",2014-08-06 07:05:00-04:00,BDSI,positive
150001.0,BioDelivery Sciences Appoints Charles J. Bramlage And Dr. Barry I. Feinberg To Its Board Of Directors,2014-07-22 08:01:00-04:00,BDSI,neutral
150002.0,BioDelivery Sciences CEO Sirgo: 'We Like to Think of Buprenorphine as a Safer Alternative',2014-07-10 18:47:00-04:00,BDSI,positive
150003.0,"BioDelivery Sciences CEO Sirgo: 'Buprenorphine is a Class-III Opioid, Less Abusable, with Less Addicting Potential than Class-II Opioids'",2014-07-10 18:45:00-04:00,BDSI,neutral
150004.0,Jim Cramer Interviews BioDelivery Sciences CEO Dr. Mark A. Sirgo on Mad Money,2014-07-10 18:38:00-04:00,BDSI,negative
150005.0,Companhia Paranaense Leads Energy Sector; Peabody Drops Over 14%,2014-07-07 15:28:00-04:00,BDSI,positive
150006.0,Silicon Motion Surges On Strong Q2 Outlook; GT Advanced Shares Slide,2014-07-07 13:05:00-04:00,BDSI,positive
150007.0,Benzinga's Volume Movers,2014-07-07 10:17:00-04:00,BDSI,neutral
150008.0,Markets Open Lower; ADM To Acquire Wild Flavors For $3 Billion,2014-07-07 10:13:00-04:00,BDSI,negative
150009.0,Stocks Hitting 52-Week Highs,2014-07-07 10:05:00-04:00,BDSI,neutral
150010.0,Morning Market Movers ,2014-07-07 09:37:00-04:00,BDSI,neutral
150011.0,Benzinga's Top #PreMarket Gainers,2014-07-07 08:08:00-04:00,BDSI,positive
150012.0,UPDATE: BioDelivery Sciences Shares RIse 18% Premarket on Positive Top-Line Phase III Results ,2014-07-07 07:25:00-04:00,BDSI,positive
150013.0,Endo and BioDelivery Sciences Announce Positive Top Line Results From Phase 3 Study,2014-07-07 07:06:00-04:00,BDSI,positive
150014.0,"Option Alert: BioDelivery Sciences Jul $12.5 Call; 3,956 Contracts Traded vs 1,282 OI; Currently $12.02",2014-06-27 09:49:00-04:00,BDSI,positive
150015.0,Biodelivery Announces Completion of Enrollment,2014-06-26 07:02:00-04:00,BDSI,neutral
150016.0,Benzinga's Volume Movers,2014-06-12 10:18:00-04:00,BDSI,neutral
150017.0,BioDelivery Sciences Receives FDA Approval For BUNAVAIL Buccal Film for Maintenance Treatment of Opioid Dependence,2014-06-09 07:03:00-04:00,BDSI,positive
150018.0,"BioDelivery Sciences Reports FDA Approval for BUNAVAIL, Expecting to Release in Late Q3",2014-06-06 17:20:00-04:00,BDSI,positive
150019.0,FDA Spokesperson Says BioDelivery Sciences' Bunavail Approved - Bloomberg,2014-06-06 16:46:00-04:00,BDSI,positive
150020.0,BioDelivery Sciences Halted News Pending,2014-06-06 16:38:00-04:00,BDSI,neutral
150021.0,3 Stocks To Consider Trading Before They Make Headlines,2014-06-06 06:51:00-04:00,BDSI,neutral
150022.0,BioDelivery To Get $10M Milestone Payment In June,2014-05-08 18:15:00-04:00,BDSI,neutral
150023.0,"BioDelivery Expects to Hear From FDA on or Around June 7, 2014 For Bunavail Drug Application",2014-05-08 18:03:00-04:00,BDSI,neutral
150024.0,BioDelivery Sciences Announces Randomization of Over 50% of Subjects in Initial Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy ,2014-05-06 07:06:00-04:00,BDSI,negative
150025.0,BioDelivery Sciences Announces First Patient Enrollment in Phase 3 Clinical Study of Clonidine,2014-04-03 07:13:00-04:00,BDSI,neutral
150026.0,BioDelivery Sciences Announces Commercialization Deal with Quintiless for Bunavail in US,2014-03-27 07:08:00-04:00,BDSI,neutral
150027.0,BioDelivery Sciences Rises 31% Premarket on Positive Top-Line Results from the Phase III Trial of BEMA Buprenorphine in Opioid Naive Patients with Chronic Pain,2014-01-24 07:51:00-05:00,BDSI,negative
150028.0,"Endo Pharma, BioDelivery Sciences Report Top-Line Results from Phase III Trial of BEMA Buprenorphine",2014-01-23 16:32:00-05:00,BDSI,neutral
150029.0,UPDATE: Endo and BioDelivery Sciences Announce Positive Top-Line Results from the Phase III Clinical Trial of BEMA Buprenorphine in Opioid Naive Patients with Chronic Pain,2014-01-23 16:31:00-05:00,BDSI,negative
150030.0,"Endo, BioDelivery Sciences Provide Update on BEMA Buprenorphine Phase III Program",2013-09-04 06:31:00-04:00,BDSI,neutral
150031.0,BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Second Quarter 2013 Financials ,2013-08-09 16:08:00-04:00,BDSI,neutral
150032.0,BioDelivery Sciences Announces Taiwan Regulatory Approval of ONSOLIS ,2013-07-29 07:03:00-04:00,BDSI,positive
150033.0,"BioDelivery Sciences Announces the Hiring of Adrian Hepner, M.D. as Vice President of Clinical Research & Regulatory Affairs ",2013-07-23 07:18:00-04:00,BDSI,neutral
150034.0,BioDelivery Sciences Adds $20 Million with Debt Financing ,2013-07-08 07:31:00-04:00,BDSI,negative
150035.0,BioDelivery Sciences Submits NDA for BUNAVAIL ,2013-06-10 07:02:00-04:00,BDSI,neutral
150036.0,"Janney Capital Initiates Coverage on BioDelivery Sciences International, Inc. at Buy, Announces $10.00 PT",2013-04-10 16:33:00-04:00,BDSI,neutral
150037.0,BioDelivery Sciences Expands Product Pipeline with Acquisition of Patented Topical Clonidine Gel for the Treatment of Painful Diabetic Neuropathy,2013-03-26 08:09:00-04:00,BDSI,negative
150038.0,UPDATE: Piper Jaffray Upgrades BioDelivery Sciences International to Overweight on Checks,2013-03-11 07:52:00-04:00,BDSI,negative
150039.0,"Piper Jaffray Upgrades BioDelivery Sciences International, Inc. to Overweight, Raises PT to $8.00",2013-03-11 06:41:00-04:00,BDSI,negative
150040.0,BioDelivery Sciences to Restate,2013-02-28 16:49:00-05:00,BDSI,neutral
150041.0,BioDelivery Sciences Halted on News,2013-02-28 16:49:00-05:00,BDSI,neutral
150042.0,"UPDATE: Piper Jaffray Initiates Coverage on BioDelivery Sciences International with Neutral Rating, $5 PT",2013-01-04 10:07:00-05:00,BDSI,neutral
150043.0,"Piper Jaffray Initiates Coverage on BioDelivery Sciences International, Inc. at Neutral, Announces $5.00 PT",2013-01-04 07:12:00-05:00,BDSI,neutral
150044.0,BioDelivery Sciences Announces $40M in Financing Commitments ,2012-11-28 07:27:00-05:00,BDSI,positive
150045.0,"Brinson Patrick Initiates Coverage on BioDelivery Sciences Internati at Market Outperform, Announces PT of $5",2012-11-16 05:51:00-05:00,BDSI,neutral
150046.0,BioDelivery Sciences Announces EU  Launch of BREAKYL,2012-10-15 07:09:00-04:00,BDSI,neutral
150047.0,BioDelivery Sciences Announces Positive Results of Pivotal Pharmacokinetic Study Comparing BEMA Buprenorphine/Naloxone (BNX) to Suboxone ,2012-09-13 07:03:00-04:00,BDSI,positive
150048.0,BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone ,2012-08-20 07:05:00-04:00,BDSI,neutral
150049.0,BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study ,2012-06-28 07:01:00-04:00,BDSI,positive
150050.0,A Peek Into The Market Before The Trading Starts,2012-05-21 07:30:00-04:00,BDSI,neutral
150051.0,BioDelivery Sciences Receives $2.5 Million Milestone from Meda for BREAKYL in E.U. ,2012-05-21 07:00:00-04:00,BDSI,neutral
150052.0,"Disney, Raytheon and Other Avenger Picks for a Heroic Portfolio",2012-05-18 06:40:00-04:00,BDSI,positive
150053.0,"UPDATE: Ladenburg Thalmann Maintains Buy Rating, Raises PT for BioDelivery Sciences International",2012-05-14 11:16:00-04:00,BDSI,neutral
150054.0,"Ladenburg Thalmann Maintains BioDelivery Sciences Internati at Buy, Raises PT from $5 to $5.5",2012-05-14 07:56:00-04:00,BDSI,neutral
150055.0,"Financial Breakfast: Morning News Summary for April 17, 2012",2012-04-17 07:34:00-04:00,BDSI,neutral
150056.0,A Peek Into The Market Before The Trading Starts,2012-04-17 07:17:00-04:00,BDSI,neutral
150057.0,BioDelivery Sciences Awarded Patent Resulting in $15 Million Milestone Payment ,2012-04-17 07:05:00-04:00,BDSI,positive
150059.0,MonoSol Rx Remains Confident in Patent Portfolio as Litigation Continues Against BioDelivery Sciences International,2012-03-12 07:30:00-04:00,BDSI,positive
150060.0,ONSOLIS Relaunch Postponed Pending Product Modification ,2012-03-12 07:16:00-04:00,BDSI,negative
150061.0,BioDelivery Sciences and FDA Reach Agreement on BNX Development Plan,2012-02-28 07:01:00-05:00,BDSI,positive
150062.0,"Financial Breakfast: Morning News Summary for February 22, 2012",2012-02-22 07:33:00-05:00,BDSI,neutral
150063.0,US Patent Office Rejects All Claims in Second MonoSol Patent,2012-02-22 07:01:00-05:00,BDSI,negative
150064.0,"Benzinga's Microcap Movers for Thursday February 16, 2012",2012-02-16 21:21:00-05:00,BDSI,neutral
150065.0,BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals,2012-02-16 08:46:00-05:00,BDSI,neutral
150066.0,Shares of BioDelivery Sciences Are Up 13% After Licensing Agreement Announcement,2012-01-12 10:45:00-05:00,BDSI,positive
150067.0,"Benzinga's Microcap Movers for Friday January 6, 2012",2012-01-08 08:53:00-05:00,BDSI,neutral
150068.0,BioDelivery Sciences Popping 160% On License and Development Agreement,2012-01-06 08:41:00-05:00,BDSI,positive
150069.0,BioDelivery Sciences Rises 140% Pre-Market on License Agreement with Endo Pharmaceuticals,2012-01-06 08:38:00-05:00,BDSI,positive
150070.0,"Financial Breakfast: Morning News Summary for January 6, 2012",2012-01-06 07:22:00-05:00,BDSI,neutral
150071.0,A Peek Into The Market Before The Trading Starts,2012-01-06 07:20:00-05:00,BDSI,neutral
150072.0,BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine; Bdsi To Receive Up to $180M Plus Royalties ,2012-01-06 06:55:00-05:00,BDSI,positive
150073.0,BioDelivery Sciences International Spiking Higher on Heavy Volume,2011-12-29 14:46:00-05:00,BDSI,neutral
150074.0,BioDelivery Sciences International Responds to Approval of Class-Wide REMS for All Transmucosal Fentanyl Products ,2011-12-29 14:39:00-05:00,BDSI,positive
150075.0,BioDelivery Sciences Announces Confirmation of Final Formulation of BEMA Buprenorphine/Naloxone Based on Positive BNX-102 Study ,2011-12-20 16:23:00-05:00,BDSI,positive
150076.0,"Financial Breakfast: Morning News Summary for November 28, 2011",2011-11-28 07:39:00-05:00,BDSI,neutral
150077.0,US Patent Office Rejects All 191 Claims in Key MonoSol Patent Asserted Against BioDelivery Sciences ,2011-11-28 07:01:00-05:00,BDSI,negative
150078.0,BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone  ,2011-11-10 07:09:00-05:00,BDSI,neutral
150079.0,BEMA Fentanyl Submitted for Marketing Authorization in Taiwan ,2011-11-07 08:59:00-05:00,BDSI,neutral
150080.0,MonoSol Rx Asserts Additional Patents to Infringement Lawsuit Against BioDelivery Sciences International  ,2011-10-26 08:33:00-04:00,BDSI,negative
150081.0,Notable Call Options Activity in BioDelivery Sciences International,2011-09-29 10:21:00-04:00,BDSI,neutral
150082.0,BioDelivery Sciences Spikes Sharply Lower after Resumption,2011-09-28 18:11:00-04:00,BDSI,negative
150083.0,PREVIEW: BioDelivery Sciences to Resume Trading at 5:45pm,2011-09-28 17:30:00-04:00,BDSI,neutral
150084.0,BioDelivery Sciences Announces Negative Results from Phase 3 Efficacy Study for BEMA Buprenorphine in Chronic Pain,2011-09-28 17:18:00-04:00,BDSI,negative
150085.0,Trading Halted on Biodelivery Sciences; News Pending,2011-09-28 17:04:00-04:00,BDSI,neutral
150086.0,BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence  ,2011-09-06 07:11:00-04:00,BDSI,positive
150087.0,Notable Call Options Activity in BioDelivery Sciences International,2011-08-22 10:31:00-04:00,BDSI,neutral
150088.0,Biodelivery Sciences Reports EPS $(0.18) May Not be Comparable to $(0.29) Est,2011-08-15 09:16:00-04:00,BDSI,neutral
150089.0,Options Brief: BioDelivery Sciences International,2011-07-25 10:13:00-04:00,BDSI,neutral
150090.0,BioDelivery Sciences Announces Completion of BEMA Buprenorphine Phase 3 Chronic Pain Study  ,2011-07-25 07:08:00-04:00,BDSI,negative
150091.0,"Rodman & Renshaw Reiterates BioDelivery Sciences Market Outperform, $5.50 PT",2011-07-01 12:00:00-04:00,BDSI,neutral
150092.0,Calls Purchased on BioDelivery Sciences International,2011-05-31 10:47:00-04:00,BDSI,neutral
150093.0,BioDelivery Sciences Announces Completion of Recruitment in BEMA Buprenorphine Phase 3 Chronic Pain Study ,2011-04-05 07:18:00-04:00,BDSI,negative
150094.0,Calls Purchased on BioDelivery Sciences International (BDSI),2011-03-31 15:36:00-04:00,BDSI,neutral
150095.0,BioDelivery Sciences Refutes Patent Claim by MonoSol Rx,2011-01-21 09:02:00-05:00,BDSI,neutral
150096.0,"MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International",2011-01-18 08:25:00-05:00,BDSI,negative
150097.0,BioDelivery Sciences HiresSenior VP of Manufacturing Operations   ,2011-01-06 10:43:00-05:00,BDSI,neutral
150098.0,Options Brief: BioDelivery Sciences International (BDSI),2010-12-28 09:38:00-05:00,BDSI,neutral
150099.0,"BioDelivery Sciences to Present at Rodman & Renshaw, Baird, and Stifel Nicolaus Investor Conferences ",2010-09-08 07:04:00-04:00,BDSI,neutral
150100.0,3-22-10 Daily Small Cap Market News and Stock Highlights from SmallCapVoice.com,2010-03-22 12:07:00-04:00,BDSI,neutral
150101.0,BioDelivery Sciences Increased After News,2010-03-22 08:29:00-04:00,BDSI,positive
150102.0,"Benzinga’s News Roundup (GAP, SYK, SPPI, BIIB, TIF, BDSI)",2010-01-12 07:55:00-05:00,BDSI,neutral
